147 related articles for article (PubMed ID: 33832919)
21. Functional characterization and identification of mouse Rad51d splice variants.
Gruver AM; Yard BD; McInnes C; Rajesh C; Pittman DL
BMC Mol Biol; 2009 Mar; 10():27. PubMed ID: 19327148
[TBL] [Abstract][Full Text] [Related]
22. XRCC2 and XRCC3 regulate the balance between short- and long-tract gene conversions between sister chromatids.
Nagaraju G; Hartlerode A; Kwok A; Chandramouly G; Scully R
Mol Cell Biol; 2009 Aug; 29(15):4283-94. PubMed ID: 19470754
[TBL] [Abstract][Full Text] [Related]
23. A hot spot for RAD51C interactions revealed by a peptide that sensitizes cells to cisplatin.
Connell PP; Siddiqui N; Hoffman S; Kuang A; Khatipov EA; Weichselbaum RR; Bishop DK
Cancer Res; 2004 May; 64(9):3002-5. PubMed ID: 15126333
[TBL] [Abstract][Full Text] [Related]
24. Disparate requirements for the Walker A and B ATPase motifs of human RAD51D in homologous recombination.
Wiese C; Hinz JM; Tebbs RS; Nham PB; Urbin SS; Collins DW; Thompson LH; Schild D
Nucleic Acids Res; 2006; 34(9):2833-43. PubMed ID: 16717288
[TBL] [Abstract][Full Text] [Related]
25. Association between RAD51, XRCC2 and XRCC3 gene polymorphisms and risk of ovarian cancer: a case control and an in silico study.
Gowtham Kumar G; Paul SFD; Martin J; Manickavasagam M; Sundersingh S; Ganesan N; Ramya R; Usha Rani G; Andrea Mary F
Mol Biol Rep; 2021 May; 48(5):4209-4220. PubMed ID: 34097201
[TBL] [Abstract][Full Text] [Related]
26. Complex formation by the human RAD51C and XRCC3 recombination repair proteins.
Masson JY; Stasiak AZ; Stasiak A; Benson FE; West SC
Proc Natl Acad Sci U S A; 2001 Jul; 98(15):8440-6. PubMed ID: 11459987
[TBL] [Abstract][Full Text] [Related]
27. RAD51, XRCC3, and XRCC2 mutation screening in Finnish breast cancer families.
Pelttari LM; Kiiski JI; Ranta S; Vilske S; Blomqvist C; Aittomäki K; Nevanlinna H
Springerplus; 2015; 4():92. PubMed ID: 25918678
[TBL] [Abstract][Full Text] [Related]
28. Domain mapping of the Rad51 paralog protein complexes.
Miller KA; Sawicka D; Barsky D; Albala JS
Nucleic Acids Res; 2004; 32(1):169-78. PubMed ID: 14704354
[TBL] [Abstract][Full Text] [Related]
29. Functional and Clinical Characterization of Variants of Uncertain Significance Identifies a Hotspot for Inactivating Missense Variants in RAD51C.
Hu C; Nagaraj AB; Shimelis H; Montalban G; Lee KY; Huang H; Lumby CA; Na J; Susswein LR; Roberts ME; Marshall ML; Hiraki S; LaDuca H; Chao E; Yussuf A; Pesaran T; Neuhausen SL; Haiman CA; Kraft P; Lindstrom S; Palmer JR; Teras LR; Vachon CM; Yao S; Ong I; Nathanson KL; Weitzel JN; Boddicker N; Gnanaolivu R; Polley EC; Mer G; Cui G; Karam R; Richardson ME; Domchek SM; Yadav S; Hruska KS; Dolinsky J; Weroha SJ; Hart SN; Simard J; Masson JY; Pang YP; Couch FJ
Cancer Res; 2023 Aug; 83(15):2557-2571. PubMed ID: 37253112
[TBL] [Abstract][Full Text] [Related]
30. Evidence for simultaneous protein interactions between human Rad51 paralogs.
Schild D; Lio YC; Collins DW; Tsomondo T; Chen DJ
J Biol Chem; 2000 Jun; 275(22):16443-9. PubMed ID: 10749867
[TBL] [Abstract][Full Text] [Related]
31. Rad51 paralog complexes BCDX2 and CX3 act at different stages in the BRCA1-BRCA2-dependent homologous recombination pathway.
Chun J; Buechelmaier ES; Powell SN
Mol Cell Biol; 2013 Jan; 33(2):387-95. PubMed ID: 23149936
[TBL] [Abstract][Full Text] [Related]
32. Distinct roles of FANCO/RAD51C protein in DNA damage signaling and repair: implications for Fanconi anemia and breast cancer susceptibility.
Somyajit K; Subramanya S; Nagaraju G
J Biol Chem; 2012 Jan; 287(5):3366-80. PubMed ID: 22167183
[TBL] [Abstract][Full Text] [Related]
33. Deleterious RAD51C germline mutations rarely predispose to breast and ovarian cancer in Pakistan.
Rashid MU; Muhammad N; Faisal S; Amin A; Hamann U
Breast Cancer Res Treat; 2014 Jun; 145(3):775-84. PubMed ID: 24800917
[TBL] [Abstract][Full Text] [Related]
34. A decade of RAD51C and RAD51D germline variants in cancer.
Boni J; Idani A; Roca C; Feliubadaló L; Tomiak E; Weber E; Foulkes WD; Orthwein A; El Haffaf Z; Lazaro C; Rivera B
Hum Mutat; 2022 Mar; 43(3):285-298. PubMed ID: 34923718
[TBL] [Abstract][Full Text] [Related]
35. Human Rad51C deficiency destabilizes XRCC3, impairs recombination, and radiosensitizes S/G2-phase cells.
Lio YC; Schild D; Brenneman MA; Redpath JL; Chen DJ
J Biol Chem; 2004 Oct; 279(40):42313-20. PubMed ID: 15292210
[TBL] [Abstract][Full Text] [Related]
36. Germline mutations in breast and ovarian cancer pedigrees establish RAD51C as a human cancer susceptibility gene.
Meindl A; Hellebrand H; Wiek C; Erven V; Wappenschmidt B; Niederacher D; Freund M; Lichtner P; Hartmann L; Schaal H; Ramser J; Honisch E; Kubisch C; Wichmann HE; Kast K; Deissler H; Engel C; Müller-Myhsok B; Neveling K; Kiechle M; Mathew CG; Schindler D; Schmutzler RK; Hanenberg H
Nat Genet; 2010 May; 42(5):410-4. PubMed ID: 20400964
[TBL] [Abstract][Full Text] [Related]
37. BRIP1, RAD51C, and RAD51D mutations are associated with high susceptibility to ovarian cancer: mutation prevalence and precise risk estimates based on a pooled analysis of ~30,000 cases.
Suszynska M; Ratajska M; Kozlowski P
J Ovarian Res; 2020 May; 13(1):50. PubMed ID: 32359370
[TBL] [Abstract][Full Text] [Related]
38. Mutation Analysis of the RAD51C and RAD51D Genes in High-Risk Ovarian Cancer Patients and Families from the Czech Republic.
Janatova M; Soukupova J; Stribrna J; Kleiblova P; Vocka M; Boudova P; Kleibl Z; Pohlreich P
PLoS One; 2015; 10(6):e0127711. PubMed ID: 26057125
[TBL] [Abstract][Full Text] [Related]
39. Xrcc3 is recruited to DNA double strand breaks early and independent of Rad51.
Forget AL; Bennett BT; Knight KL
J Cell Biochem; 2004 Oct; 93(3):429-36. PubMed ID: 15372620
[TBL] [Abstract][Full Text] [Related]
40. RAD51C germline mutations found in Spanish site-specific breast cancer and breast-ovarian cancer families.
Blanco A; Gutiérrez-Enríquez S; Santamariña M; Montalban G; Bonache S; Balmaña J; Carracedo A; Diez O; Vega A
Breast Cancer Res Treat; 2014 Aug; 147(1):133-43. PubMed ID: 25086635
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
